U.S. Department of Justice
United States Joins Suits Against Scios and Johnson & Johnson
Published in Law and Health Weekly, March 7th, 2009
The United States has intervened in two whistleblower suits filed in the Northern District of California against the drug manufacturer Scios Inc. and its parent company, Johnson & Johnson Inc., alleging that the companies marketed the cardiac drug Natrecor for a use not approved by the Food and Drug Administration (FDA) and caused false and fraudulent claims to be submitted to the federal health care programs, the Justice Department announced. Such an unapproved use is also known as an "off-label" use because it is not included in the drug's FDA approved product label.
Under the Food, Drug and Cosmetic Act, a company must specify the intended uses of a product in its...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- AARP Pennsylvania
Divided We Fail Pushes to Keep Health Care Reform as a Top Priority for Congress and the New Administration - Acacia Research Corporation
Acacia Research Reports Fourth Quarter and Year End Financial Results - Acacia Research Corporation
Acacia Subsidiary Enters into a License Agreement with LookSmart - Accertify
Tickets.com Selects Accertify - Adheris, Inc.
New Study Measures Effects of Medicare Part D on Prescription Drug Use, Cost Sharing for Senior Beneficiaries - AFC Enterprises, Inc.
AFC Files Request for Declaratory Judgment and Arbitration Against Supplier - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
